Shionogi & Co. Ltd.

In News

Shionogi Announces U.S. Government Procurement of Fetroja® (cefiderocol) Through BARDA's Project BioShield to Support National Preparedness for Drug-Resistant Bacterial Threats - Business Wire

Business Wire - Aug 28, 2026

Shionogi CEO says firm is pursuing acquisitions and mulling expanded U.S. production - The Japan Times

The Japan Times - Aug 05, 2026

Shionogi & Co., Ltd. - Announces U.S. Government Procurement Of Fetroja (Cefiderocol) Through Barda's Project Bioshield - TradingView

TradingView - Aug 28, 2026

Shionogi Abolishes Retirement Age, Keeps Wages Tied to Roles - 조선일보

조선일보 - Aug 28, 2026

Shionogi makes the call on COVID pill Xocova TV spot - Fierce Pharma

Fierce Pharma - Jul 30, 2026

Shionogi weighs future of FXS drug after double Phase III miss - Clinical Trials Arena

Clinical Trials Arena - May 14, 2026

Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats - CIDRAP

CIDRAP - Apr 09, 2026

Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats - PharmExec.com

PharmExec.com - Apr 09, 2026

Shionogi Secures US Contract to Expand Antibiotic Manufacturing and Biothreat Preparedness - Contagion Live

Contagion Live - Apr 09, 2026

Shionogi Selected as a “DX Stock 2026”｜塩野義製薬 - Shionogi Inc.

Shionogi Inc. - Apr 10, 2026

F2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 test - Fierce Biotech

Fierce Biotech - Jun 18, 2026

Shionogi-Backed Apnimed Seeks to Raise $160 Million in US IPO - Bloomberg.com

Bloomberg.com - Jul 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment